P M Loadman - JoVE Visualize

Showing results (11-20 of 40) with videos related to

Pageof 4

Sort By:

Investigational New Drugs|August 1, 1992

Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.

Journal of Chromatography. B, Biomedical Applications|October 20, 1995

Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatographyA J Moore, P M Loadman, D A Devine, et al.

European Journal of Cancer & Clinical Oncology|August 1, 1988

Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.

British Journal of Cancer|February 1, 1987

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)M C Bibby, J A Double, R M Phillips, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.

International Journal of Cell Cloning|March 1, 1991

The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor modelR M Phillips, M C Bibby, J A Double, et al.

Journal of the National Cancer Institute|February 1, 1989

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapyM C Bibby, J A Double, P M Loadman, et al.

British Journal of Cancer|March 1, 1992

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in miceM C Bibby, P M Loadman, A F al-Ghabban, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1996

ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumourJ R Masters, B J McDermott, S Harland, et al.

Anticancer Research|April 19, 2000

Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinomaK Grosios, P M Loadman, D J Swaine, et al.

Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:

Pageof 4

Investigational New Drugs|August 1, 1992

Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.

Journal of Chromatography. B, Biomedical Applications|October 20, 1995

Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatographyA J Moore, P M Loadman, D A Devine, et al.

European Journal of Cancer & Clinical Oncology|August 1, 1988

Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.

British Journal of Cancer|February 1, 1987

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)M C Bibby, J A Double, R M Phillips, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.

International Journal of Cell Cloning|March 1, 1991

The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor modelR M Phillips, M C Bibby, J A Double, et al.

Journal of the National Cancer Institute|February 1, 1989

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapyM C Bibby, J A Double, P M Loadman, et al.

British Journal of Cancer|March 1, 1992

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in miceM C Bibby, P M Loadman, A F al-Ghabban, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1996

ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumourJ R Masters, B J McDermott, S Harland, et al.

Anticancer Research|April 19, 2000

Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinomaK Grosios, P M Loadman, D J Swaine, et al.

Pageof 4